-
Antibody production
COVID-19 antibodies, antigens, and services
SARS-CoV-2 is a new Betacoronavirus responsible for the COVID-19 respiratory outbreak. The virus is also the third of the genus known to have been transmitted from animals to humans and…
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Antibody production
The best CHO expression system kits on the market
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Peptide synthesis
Are peptide vaccines providing a safer and more cost-effective alternative to conventional vaccines in protecting against life-threatening and chronic diseases?
Read more -
Antibody production
When you should choose to develop a peptide antibody for your project
Read more
-
Blog
Which approach should you choose to get a species-specific veterinary monoclonal antibody? A decision guide
Read more -
Customers success stories
Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology
Read more -
Customers success stories
Accelerating Translational Research: How Phage Display Technology Delivered High-Affinity Antibodies for Groundbreaking Applications
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Customers success stories
The Path of Creating an Innovative IL-17A Antibody for Autoimmune Disorders
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more